InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.00%
)
US TECH 100
19,215.60
(
0.00%
)
Dow Jones
39,127.80
(
0.00%
)
Brent Oil
85.09
(
0.73%
)
Bitcoin
61,629.03
(
1.34%
)
Post# of 40501
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Ubertino

Send PM Follow Ignore
Followers 113
Posts 25553
Boards Moderated 4
Alias Born 02/01/2004

Ubertino

Re: Ubertino post# 13238

Tuesday, 02/02/2016 7:32:46 PM

Tuesday, February 02, 2016 7:32:46 PM

Post# of 40501
hepatitis b virus

INO-1800 SynCon® immunotherapy for hepatitis B virus


Preclinical

Hepatitis B virus
Milestone

Initiated phase I trial 2Q 2015

Description
INO-1800 is a multi-antigen SynCon® DNA immunotherapy targeting hepatitis B virus clades A & C surface antigens & HBV core antigens.

Development Status
In 2013, Inovio entered into an exclusive worldwide collaboration with Roche to develop and commercialize Inovio’s hepatitis B multi-antigen DNA immunotherapy. The initiation of a phase I trial began in 2Q 2015 to test the safety, tolerability, and immunogenicity of INO-1800 alone or in combination with INO-9112, Inovio’s IL-12-based immune activator.

http://www.inovio.com/products/infectious-disease-vaccines/hepatitis/hbv/

Roche video:

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent INO News
More INO News
InvestorsHub NewsWire

FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM

Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!